Our Partners

Advancing translational innovation through collaboration

CVMD-TRP thrives on robust and invaluable collaborations between ourselves, different local and international industry leaders, as well as academic partners, amplifying innovation and expertise exchange. Our strategic partnerships aim at accelerating our contribution to cardiovascular metabolic disease research on a global stage. 

Duke-NUS: CVMD programme

NHRIS @ NHCS

NTU CePHaS

LKC Medical School

IMCB ASTAR

GIS ASTAR

BII ASTAR

CADENCE @ CRIS

PRECISE @ CRIS

University of Cambridge

Kings College London

University of Pennsylvania

UT Southwestern Medical Center

Max-Planck-Institut für Herz- und Lungenforschung

Cambridge Cardiovascular

United Arab Emirates University

Universitätsklinikum Hamburg-Eppendorf

Albert Einstein College of Medicine

University of Colorado Anschutz Medical Campus

Chinese Academy of Sciences

Stanford Cardiovascular Institute

Queen Mary University of London

Huazhong University of Science And Technology

Imperial College London

Universitas Gadjah Mada

UKM Medical Molecular Biology Institute

Novo Nordisk

Astra Zeneca